Lv2
180 积分 2026-02-02 加入
CXCL10 drives pancreatic ductal adenocarcinoma progression through CXCR3-ERK/MAPK signaling
14天前
已完结
Malate, a natural inhibitor of 6PGD, improves the efficacy of chemotherapy in lung cancer
18天前
已完结
HOMER3 as a prognostic and immune-related biomarker in pan-cancer and esophageal carcinoma: Insights from bioinformatics and functional validation
20天前
已完结
Surgical management of the primary tumor in stage M1a-IVA non-small cell lung cancer
26天前
已完结
JOSD1 drives hepatocellular carcinoma malignancy by modulating the ubiquitination-lactylation switch on PGAM1
2个月前
已完结
Bile acids activate cancer-associated fibroblasts and induce an immunosuppressive microenvironment in cholangiocarcinoma
2个月前
已完结
Targeting KDM4C enhances CD8+ T cell mediated antitumor immunity by activating chemokine CXCL10 transcription in lung cancer
2个月前
已完结
IRF1 transcriptionally up-regulates CXCL10 which increases CD8+ T cells infiltration in colorectal cancer
3个月前
已完结
CXCL10 mediates CD8+ T cells to facilitate vessel normalization and improve the efficacy of cetuximab combined with PD-1 checkpoint inhibitors in colorectal cancer
3个月前
已完结
Targeting RRBP1 reverses immune evasion and enhances immunotherapy efficacy via the CXCL10-CXCR3 axis in bladder cancer
3个月前
已完结
皖公网安备34019202002308
